Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-12

Clinical Trial Update: Synthetic THC And Blood Pressure [Phase 2, Phase 3]

View source ↗

Summary

The Mayo Clinic is sponsoring a clinical trial evaluating Synthetic THC for blood pressure in Phase 2/Phase 3, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Synthetic THC (tetrahydrocannabinol)

Snippet

Sponsor: Mayo Clinic | Conditions: Blood Pressure | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING